State Street’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

State Street’s Portfolio PTX Stock Details PTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,162	Closed	-$14K	–	3738
2016 Q3	$14K	Hold	2,162	–	–	﹤0.01%	3557
2016 Q2	$9K	Sell	2,162 -57,265	-96%	-$374K	﹤0.01%	3706
2016 Q1	$625K	Buy	59,427 +5,907	+11%	+$117K	﹤0.01%	3309
2015 Q4	$1.58M	Sell	53,520 -198	-0.4%	-$5.99K	﹤0.01%	3086
2015 Q3	$1.7M	Buy	53,718 +7,893	+17%	+$378K	﹤0.01%	3062
2015 Q2	$2.71M	Buy	45,825 +1,345	+3%	+$94.9K	﹤0.01%	2945
2015 Q1	$4.75M	Buy	44,480 +4,206	+10%	+$401K	﹤0.01%	2586
2014 Q4	$3.78M	Buy	40,274 +13,621	+51%	+$1.3M	﹤0.01%	2715
2014 Q3	$2.05M	Buy	26,653 +1,631	+7%	+$128K	﹤0.01%	3002
2014 Q2	$2.25M	Buy	25,022 +5,312	+27%	+$326K	﹤0.01%	3016
2014 Q1	$1.05M	Buy	19,710 +1,306	+7%	+$43.1K	﹤0.01%	3248
2013 Q4	$464K	Buy	18,404 +1,037	+6%	+$24.7K	﹤0.01%	3368
2013 Q3	$473K	Buy	17,367 +6,697	+63%	+$215K	﹤0.01%	3355
2013 Q2	$385K	Buy	+10,670	New	+$400K	﹤0.01%	3273

Other funds holding PTX

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street's PTX Position: Q4 2016 in Review

State Street sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q4 2016, closing a stake of 2,162 shares — an estimated $14K sold.

State Street first reported a position in PTX in Q2 2013 and held it in 14 quarters. The position peaked at $4.75M in Q1 2015. 34 funds tracked by Wall St. Rank hold PTX as of Q4 2016.

State Street reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q4 2016 after selling out during the quarter.
State Street sold 2,162 Pernix Therapeutics Holdings, Inc. shares in Q4 2016, an estimated $14K.
State Street first reported a position in Pernix Therapeutics Holdings, Inc. in Q2 2013 and held it in 14 quarters.
State Street's Pernix Therapeutics Holdings, Inc. position peaked at $4.75M in Q1 2015.
34 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q4 2016.

Based on State Street's 13F filing for Q4 2016, filed 9 Feb 2017.